Effect of mTORC Agonism via MHY1485 with and without Rapamycin on C2C12 Myotube Metabolism
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25136819 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Norah E Cook und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Human Performance, High Point University, High Point, NC 27262-3598, USA. Hauptthemen laut MEDLINE: Muscle Fibers, Skeletal, Sirolimus, Mitochondria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health and Human Performance within the Congdon School of Health Sciences, High Point University Undergraduate Research and Creative Works Small Project Support Grant.
Abstract (Originalsprache)
The mechanistic target of rapamycin complex (mTORC) regulates protein synthesis and can be activated by branched-chain amino acids (BCAAs). mTORC has also been implicated in the regulation of mitochondrial metabolism and BCAA catabolism. Some speculate that mTORC overactivation by BCAAs may contribute to insulin resistance. The present experiments assessed the effect of mTORC activation on myotube metabolism and insulin sensitivity using the mTORC agonist MHY1485, which does not share structural similarities with BCAAs.
Methods
C2C12 myotubes were treated with MHY1485 or DMSO control both with and without rapamycin. Gene expression was assessed using qRT-PCR and insulin sensitivity and protein expression by western blot. Glycolytic and mitochondrial metabolism were measured by extracellular acidification rate and oxygen consumption. Mitochondrial and lipid content were analyzed by fluorescent staining. Liquid chromatography-mass spectrometry was used to assess extracellular BCAAs.
Results
Rapamycin reduced p-mTORC expression, mitochondrial content, and mitochondrial function. Surprisingly, MHY1485 did not alter p-mTORC expression or cell metabolism. Neither treatment altered indicators of BCAA metabolism or extracellular BCAA content.
Conclusion
Collectively, inhibition of mTORC via rapamycin reduces myotube metabolism and mitochondrial content but not BCAA metabolism. The lack of p-mTORC activation by MHY1485 is a limitation of these experiments and warrants additional investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health and Human Performance, High Point University, High Point, NC 27262-3598, USA.
- Department of Chemistry, High Point University, High Point, NC 27262-3598, USA.
ORCID-Profile: Pamela M Lundin, Roger A Vaughan
Förderung
- Department of Health and Human Performance within the Congdon School of Health Sciences
- High Point University Undergraduate Research and Creative Works Small Project Support Grant
Zitieren
APA
Cook, N. E., McGovern, M. R., Zaman, T., Lundin, P. M., & Vaughan, R. A. (2024). Effect of mTORC Agonism via MHY1485 with and without Rapamycin on C2C12 Myotube Metabolism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136819
Vancouver
Cook NE, McGovern MR, Zaman T, Lundin PM, Vaughan RA. Effect of mTORC Agonism via MHY1485 with and without Rapamycin on C2C12 Myotube Metabolism. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136819
BibTeX
@article{Cook2024,
author = {Cook, Norah E and McGovern, Macey R and Zaman, Toheed and Lundin, Pamela M and Vaughan, Roger A},
title = {Effect of mTORC Agonism via MHY1485 with and without Rapamycin on C2C12 Myotube Metabolism},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25136819}
}
EUVIMED